Search results
Britain Poised to Offer Eli Lilly’s Weight-Loss Drug to Patients
Bloomberg· 8 hours agoEli Lilly & Co.’s Mounjaro is being recommended for weight loss for some UK patients with obesity,...
Britain considers offering Lilly weight-loss drug on better terms than Wegovy
Reuters· 3 hours agoIn its draft roadmap for Mounjaro, known chemically as tirzepatide and sold in the U.S. for weight ...
Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030,...
INSIDER via Yahoo News· 3 days agoZepbound is Eli Lilly's new weight-loss drug.Brendan McDermid/Reuters The anti-obesity
ETFs to Profit from the Weight Loss Drug Boom
Zacks via Yahoo Finance· 4 hours agoWhile there's a lot of excitement around AI, particularly with NVIDIA NVDA, shares of two companies that dominate the weight-loss drug
Ozempic-Maker Novo Nordisk Sues Pharmacies And Weight Loss Clinics For Allegedly Selling Impure...
Forbes· 6 days agoNovo Nordisk has filed nine lawsuits against medical spas, wellness clinics and pharmacies for...
Structure Therapeutics (GPCR) Stock Soars 60% on Weight Loss Drug Success
InvestorPlace· 1 day agoStructure Therapeutics (NASDAQ:GPCR) stock is surging today, up 60% after the biotech company...
Weight Loss Drug Market To Rocket To $130B By 2030 With Eli Lilly, Novo Nordisk In Lead...
Benzinga· 5 days agoGoldman Sachs analysts re-rated Eli Lilly And Co LLY and Novo Nordisk A/S NVO, citing the potential...
William Blair Commentary: Waistlines and GLP1-s--Expanding in Unison
GuruFocus.com via Yahoo Finance· 3 hours agoFurther analysis from our internal models anticipates...by the broad utility of GLP-1 medications,...
...Nordisk (NYSE:NVO), Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM), Eli Lilly and Co (NYSE:LLY)
Benzinga· 5 days agoThis ETF presents a unique opportunity for investors to gain exposure to the weight-loss sector...
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.
Motley Fool via Yahoo Finance· 1 day agoWhereas...year of treatment to help patients shed as much as 21% of their body weight, in its phase...